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osting by EAbstract This work was conducted to investigate diet supplement of king oyster mushroom fruit-
ing bodies on biochemical and histological changes in hypercholesterolemic rats. Six-week old
female Sprague–Dawley albino rats were divided into three groups of 10 rats each. The feeding
of 5% powder of the fruiting bodies of Pleurotus eryngii to hypercholesterolemic rats reduced their
plasma total cholesterol, triglyceride, low-density lipoprotein, total lipid, phospholipids, and LDL/
HDL ratio by 24.05%, 46.33%, 62.50%, 24.63%, 19.22%, and 57.14%, respectively. Mushroom
also signiﬁcantly reduced body weight in hypercholesterolemic rats. However, it had no adverse
effects on plasma albumin, total bilirubin, direct bilirubin, creatinine, blood urea nitrogen, uric
acid, glucose, total protein, calcium, sodium, potassium, chloride, inorganic phosphate, magnesium,
and enzyme proﬁles. Feeding mushroom increased total lipid and cholesterol excretion in feces. The
plasma lipoprotein fraction, separated by agarose gel electrophoresis, indicated that P. eryngii sig-
niﬁcantly reduced plasma b and pre-b-lipoprotein, while increased a-lipoprotein. A histological
study of hepatic cells by conventional hematoxylin–eosin and oil red O staining showed normal
ﬁndings for mushroom-fed hypercholesterolemic rat. The present study suggests that 5% P. eryngiiDivision of Life Sciences,
g, Incheon 406-840, Republic
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404 N. Alam et al.diet supplement provided health beneﬁts by acting on the atherogenic lipid proﬁle in hypercholes-
terolaemic rats. Therefore, king oyster mushroom could be recommended as a natural cholesterol
lowering substance within the human diet.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Pleurotus eryngii is known as king oyster mushroom. It is a
popular and commercially cultivated edible mushroom in Kor-
ea (Ro et al., 2007). Mushrooms have long been widely appre-
ciated for their good ﬂavor and texture. Recently, they are
recognized as a nutritious food as well as an important source
of biologically active compounds of medicinal purposes (Alam
et al., 2009a).
Increased plasma levels of total cholesterol (TC), low-density
lipoprotein (LDL) and very low-density lipoprotein (VLDL) as
well as lowered levels of high-density lipoprotein (HDL) choles-
terol have been identiﬁed as major risk factors in the develop-
ment of coronary artery disease (Alberts et al., 1989). Edible
mushrooms are rich in their high-ﬁber content, sterols, proteins,
microelements and a low caloriﬁc value that are almost ideal for
diets designed to prevent cardiovascular diseases (Alam et al.,
2008; Breene, 1990). Early attempts to identify inhibitors of cho-
lesterol synthesis resulted in the development of inhibitors that
could affect stages in the biosynthetic pathway for cholesterol
formation. A major rate-limiting step in the pathway is at the
level of the microsomal enzyme 3-hydroxy-3-methylglutaryl-
coenzyme-A (HMG-CoA) reductase. HMG-CoA reductase
occurs early in the biosynthetic pathway and is among the ﬁrst
committed steps to cholesterol formation that catalyzes the
reductions of HMG-CoA into mevalonate (Rodwell et al.,
1976).
The genus Pleurotus has several species that produce
mevinolin (Gunde-Cimerman et al., 1993). Oyster mushroom
has been shown to produce the highest amount of lovastatin
in the fruiting bodies, especially in the lamellae or gills.
The addition of 5% dried fruiting bodies of oyster mush-
room to a high-cholesterol diet effectively reduced cholesterol
accumulation in the plasma and liver of experimental rats
redistributing cholesterol in favor of HDL, reduced produc-
tion of TC, VLDL, and LDL, reduced cholesterol absorption
and HMG-CoA reductase activity in the liver (Hossain et al.,
2003). It has been suggested that mushrooms could be recom-
mended as a natural cholesterol reducing substance within the
human diet. In spite of the medicinal importance or the thera-
peutic potential of P. eryngii, there have not been studies on
antihyperlipidemic activities. Moreover, comprehensive studies
on the antihyperlipidemic properties of this mushroom are not
available. The aim of the present study is to evaluate the anti-
hyperlipidemic potentials from the fruiting bodies of P. eryngii
in atherogenic lipid and liver function, and histology of hyper-
cholesterolemic rats.
2. Materials and methods
This study was carried out from February 2010 to January
2011 at the Animal House and Laboratory of Applied Micro-
biology, Division of Life Sciences and the experimental proto-
cols were approved by ethical committee of the University of
Incheon, Republic of Korea. All experimental procedures wereperformed in accordance with the guide for the care and use of
experimental animals.
2.1. Mushroom
Fresh fruiting bodies of P. eryngii were obtained from Hanul-
tari mushroom farm, Korea. A pure culture was deposited in
the Culture Collection and DNA Bank of Mushroom
(CCDBM), Division of Life Sciences, University of Incheon,
Korea and acquired accession number, IUM-4030. Fresh fruit-
ing bodies were dried with hot air at 40 C for 48 h and
pulverized.
2.2. Animals
Thirty female Sprague–Dawley albino rats (101 ± 4.2 g, 6-
weeks old, purchased from Central Lab. Animal Inc., Seoul,
Korea) were used. All rats were acclimated to the animal room
for 1 week. The rats were housed in an animal room at
23 ± 2 C under a 12 h dark–light cycle (17:00–5:00 h) and rel-
ative humidity of 50–60%. Rats were divided into three feed
groups: a basal diet (normocholesterolemic control rats;
NC), basal diet with 1% cholesterol (hypercholesterolemic
rats; HC), and a basal diet with 1% cholesterol and 5% P.
eryngii powder (mushroom-fed hypercholesterolemic rats;
HC + PE). The composition of the basal diet was as follows
(in g/100 g): wheat ﬂour 50; rice power 11.25; wheat bran 19;
casein 8; egg white 10; soybean oil 1; table salt 0.5; vitamin
mixture 0.125; mineral mixture 0.125. The composition of
the vitamin mixture in the diet was as follows (g/100 g vitamin
mixture): retinyl acetate 9.5 · 104, cholecalciferol 1.2 · 103,
a-tocopherol acetate 0.05, thiamine hydrochloride 2.4, nico-
tinic acid 12, riboﬂavin 2.4, D-calcium pantothenate 9.6, pyri-
doxine hydrochloride 1.2, folic acid 9.5 · 102, vitamin K 0.25,
cyanocobalamine 9.5 · 10-3, inositol 47.95 and ascorbic acid
24.0. The composition of the mineral mixture added to diet
was as follows (g/100 g of mineral): calcium gluconate 28.5,
K2HPO4 17.3, CaCO3 26, MgSO4 12.6, KCl 12.6, CuSO4
0.06, FeSO4 0.3, MnSO4 0.55, NaF 2.5 · 104, KI 9 · 104, so-
dium molybdate 3 · 104, SeO2 3 · 104, and CrSO2
1.5 · 103. Rats were fed for 42 days.
2.3. Plasma biochemical analysis
At the end of the experimental period, overnight-fasted animals
were sacriﬁced under injectable anesthetic (Zoletil 50; VIRBAC
Laboratories, Carros, France). Blood samples were collected
with a disposable plastic syringe into heparinized tubes. Plasma
was prepared by centrifugation at 2493·g for 10 min. Plasma tri-
glyceride (TG) concentrationwasmeasured enzymatically using
the glycerophosphate oxidase assay. Plasma total cholesterol
(TC), high-density lipoprotein cholesterol (HDL-C), low-
density lipoprotein cholesterol (LDL-C), very low-density
lipoprotein cholesterol (VLDL-C), total lipid (TL), and
phospholipid (PL) levels were measured enzymatically by the
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commercially available assay kits (Sekisui Medical Co., Ltd.,
Tokyo, Japan). Plasma albumin, total bilirubin, direct bilirubin,
creatinine, blood urea nitrogen, uric acid, glucose, total protein,
and electrolyte parameters, including calcium, sodium, potas-
sium, chloride, inorganic phosphate, and magnesium were mea-
sured by standard methods using an auto analyzer (Hitachi
7600-210; Hitachi, Tokyo, Japan).
Very low density lipoprotein cholesterol was calculated as
follows:
VLDL-C = [TC – (HDL-C + LDL-C)].
2.4. Plasma enzyme analysis
The activity of the plasma alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) was determined using the
kinetic method (Burtis and Ashwood, 2006). Plasma alkaline
phosphatase (ALP) activity was determined using 4-nitrophenyl
phosphate. ALP catalyzes the hydrolysis of 4-nitrophenyl phos-
phate, forming phosphate and free 4-nitrophenol, which is col-
orless in dilute acid solutions. But, under alkaline conditions
4-nitrophenol is converted into the 4-nitrophenoxide ion, which
is an intense yellow color. The absorbance of this color
compound was measured spectrophotometrically at 420 nm to
determine plasma ALP activity.
2.5. Fecal total lipid and cholesterol analysis
Feces were collected for 7 days before and at the end of 42 days,
lyophilized, and then milled into powder. Total lipids were ex-
tracted with chloroform/methanol (2:1 v/v) according to the
method of Folch et al. (1957). One gram of fecal powder was
mixed with 10 ml of chloroform and 5 ml of methanol solution
and stirred at 150 rpm for 3 days at room temperature. The sus-
pensionwas ﬁltered throughWhatmanNo. 2 ﬁlter paper (What-
man, Maidstone, UK), the methanol was aspirated, and the
chloroform was evaporated. The extracted lipids were then
weighed. Two milliliters of H2O was added, and a suspension
was created using a bath sonicator. This suspension was used
to estimate fecal cholesterol content, which was estimated by
the enzymatic method using the cholesterol oxidase assay.
2.6. Plasma lipoprotein separation by agarose gel electrophoresis
Plasma lipoprotein fractions were determined by agarose gel
electrophoresis (Kido et al., 2001). Three lipoprotein fractions
were detected by electrophoresis, which will henceforth be re-
ferred to as b-lipoprotein (LDL), pre-b-lipoprotein (VLDL),
and a-lipoprotein (HDL). Sample application (2 ll), electro-
phoresis (80 V, 30 min.), staining (FatRed 7B), drying, and den-
sitometric scanning (525 nm) were performed automatically by
the Helena TITAN GEL Lipoprotein Electrophoresis System
(Helena Laboratories, Beaumont, TX, USA). After electropho-
resis, lipoprotein fractions were visualized with enzymatic
staining reagents. The visualized gel plate was scanned on a den-
sitometer, and the lipoprotein scanning patterns were identiﬁed
using analytical software (electrophoresis data bank, K.K.
Helena Laboratories, Saitama, Japan). The scanned patterns
were divided into lipoprotein fractions using the nadirs of the
lipoprotein sequential curve. Lipoprotein levels were estimated
from the area percentages and total concentrations.2.7. Histological analysis of liver
Liver tissues were rapidly dissected, ﬁxed in liquid nitrogen and
10% formalin solution, and stored until use at80 C. A repre-
sentative part of the frozen tissues was processed with a cryo
microtome (Cryotome FSE Cryostat; Thermo Electron Corp.,
Cambridge, MA, USA) using sections 5-lm thick and stained
with oil red-O (Bayliss-High, 1990). A representative part of
the formalin ﬁxative liver tissues was processed for 4-lm thick
parafﬁn embedded sections using a microtome (Microtome
HM 450; Thermo Electron Corp.) and then stained with hema-
toxylin and eosin. Both stained tissue samples were then exam-
ined and photographed under a light microscope to assess the
presence of lipid. Digital images were obtained using an Olym-
pus BX51 microscope equipped with a Camedia C3040ZOOM
digital camera (Olympus America Inc., Melville, NY, USA).
All images were taken under 40· magniﬁcation.
2.8. Statistical analysis
Results are expressed as means ± SD. Intergroup differences
were analyzed by a one-way analysis of variance followed by
post-hoc tests. The SPSS ver. 11.5 (SPSS Inc., Chicago, IL,
USA) were used for analysis. A p 6 0.05 was considered statis-
tically signiﬁcant.
3. Results and discussion
3.1. Effect of Pleurotus eryngii on bodyweight
The results on the effect of P. eryngii in the body weight after 6
weeks among the NC, HC, and HC + PE rats were
243 ± 12.5, 249 ± 11.9, and 224 ± 12.4, respectively. Feeding
of P. eryngii reduced the body weight in hyper and normocho-
lesterolemic rats by 16.89% and 13.38%, respectively. This
ﬁnding is of special signiﬁcance because obesity is associated
with numerous diseases including diabetes, atherosclerosis,
coronary heart disease and others (Alam et al., 2009b).
3.2. Effect of Pleurotus eryngii on plasma lipid proﬁle
Plasma lipid proﬁles concentrations in NC, HC, and HC + PE
group rats after P. eryngii feeding for 6 weeks have been pre-
sented in Table 1. Plasma TC, TG, HDL-C, LDL-C, VLDL-
C, TL, and PL in HC rats increased by 17.09%, 36.68%,
12.23%, 22.35%, 19.01%, 19.82%, and 16.14%, respectively,
compared with levels in NC rats, whereas these parameters de-
creased signiﬁcantly by 24.05%, 46.33%, 10.90%, 62.50%,
19.79%, 24.63%, and 19.22%, respectively, in HC + PE rats
compared with HC rats. The ratio of plasma LDL and HDL
is shown in Fig. 1. In HC rats, this ratio increased by 8.89%,
compared with NC rats, whereas this ratio was reduced signiﬁ-
cantly by 57.14% in HC+ PE rats compared with HC rats.
The results show that feeding 5% P. eryngii to hypercholes-
terolemic rats signiﬁcantly ameliorated the plasma atherogenic
lipid proﬁles in experimentally induced HC rats. Rats are par-
ticularly resistant to the development of hypercholesterolemia
and atherosclerosis (Andrus et al., 1956) and have a strong abil-
ity to maintain their plasma cholesterol levels (Fujioka et al.,
1995). Therefore, to induce hypercholesterolemia or atheroscle-
rosis in rats, cholesterol feeding is used with other additives,
Table 1 Effects of Pleurotus eryngii on plasma lipid proﬁles in hypercholesterolemic rats.
Parameter NC (n= 10) HC (n= 10) HC+ PE (n= 10)
Plasma parameters
TC (mg/dl) 103.0 ± 5.3a 120.6 ± 10.3b 91.6 ± 3.8a
TG (mg/dl) 63.8 ± 11.3a 87.2 ± 12.8b 46.8 ± 5.9c
HDL-C (mg/dl) 37.6 ± 2.9 42.2 ± 2.2 37.6 ± 4.1
LDL-C (mg/dl) 17.0 ± 5.8a 20.8 ± 2.3a 7.8 ± 1.8b
VLDL-C (mg/dl) 48.4 ± 6.3 57.6 ± 7.8 46.2 ± 4.1
TL (mg/dl) 328.0 ± 9.8a 393.0 ± 4.8b 296.2 ± 14.4c
PL (mg/dl) 158.6 ± 9.8a 184.2 ± 11.0b 148.8 ± 9.8a
AST 63.4 ± 9.1 70.8 ± 8.4 58.8 ± 8.1
ALT 57.4 ± 10.9a,b 65.6 ± 3.0a 48.2 ± 7.2b
ALP 164.8 ± 7.7a,b 177.2 ± 9.4a 148.4 ± 12.8b
Fecal parameters
Total lipid (U/l) 24.6 ± 3.2a 55.5 ± 4.5b 61.3 ± 4.2b,c
Cholesterol (U/l) 3.8 ± 0.6a 13.4 ± 0.8c 14.8 ± 1.3c
Values are given means ± S.D. Values in the same row that do not share a common superscript are signiﬁcantly different at p 6 0.05.
Figure 1 Effects of Pleurotus eryngii mushroom on plasma
LDL/HDL ratio in hypercholesterolemic rats. Values represented
are the means ± SD (n= 10). Different symbols indicate signif-
icant differences at p 6 0.05.
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drug), which increase intestinal absorption of cholesterol (Dol-
phin and Forsyth, 1983). However, in the present study, the
addition of 1% cholesterol to the basal diet without bile acids
and/or anti-thyroid drugs produced hypercholesterolemia in
the rats, because cholesterol feeding itself increases bile acid
secretion by approximately three to four-folds in rats (Uchida
et al., 1996). The 17.09% increase in plasma cholesterol in the
hypercholesterolemic rats in the present study was comparable
with that reported by Bobek et al. (1995), who feed rats
cholesterol (0.3%) diet with added bile acids (0.5%) and
showed a 1.7-fold higher cholesterolemia in their cholesterol-
fed rats than normal rats. In this experiment, feeding 5%mush-
rooms to hypercholesterolemic rats signiﬁcantly repressed the
increment of plasma cholesterol. The mechanism by which
mushrooms reduce plasma lipoprotein levels in hypercholester-
olemic rats is not clearly understood. Mushrooms contain the
hypocholesterolemic agent mevinolin (Gunde-Cimerman
et al., 1993), which may be involved in decreasing the activity
of HMG-CoA reductase. Thus, feeding mushrooms may
involve suppression of endogenous cholesterol biosynthesis
by inhibiting HMG-CoA reductase activity.3.3. Effect of Pleurotus eryngii on plasma enzyme proﬁles
Lower plasma AST, ALT, and ALP concentrations were ob-
served in king oyster mushroom-fed hypercholesterolemic rats
than normocholesterolemic rats (Table 1). No signiﬁcant dif-
ference was observed in the activities of plasma AST in the
NC, HC, or HC + PE rats groups. Plasma ALT and ALP
activities were signiﬁcantly higher in HC rats than in NC rats,
whereas 5% mushroom-fed hypercholesterolemic rat revealed
decreased plasma AST, ALT, and ALP activities by 16.95%,
26.52%, and 16.25%, respectively.
Due to the increasing frequency of antihyperlipidemic drug
use and their common side effects, there is a need to identify
natural products with few or no side effects. Thus, develop-
ment continues for highly effective natural ingredients from
food, such as mushrooms, which decrease hyperlipidemia
(Alarco´n et al., 2003). Previous studies have shown that AST
and ALT are typically elevated following cellular damage as
a result of enzyme leakage from the cells into blood (Alam
et al., 2011). Therefore, the increased enzyme activities result-
ing from the mushroom treatment may prevent oxidative dam-
age by detoxifying reactive oxygen species; thus, reducing
hyperlipidemia.
3.4. Effect of Pleurotus eryngii on fecal total lipid and
cholesterol
The fecal total lipid and cholesterol of the 5% P. eryngii-fed
hypercholesterolemic rats signiﬁcantly increased by 2.5 and
3.9-folds, respectively, compared with NC rats (Table 1). Thus,
the decreased plasma cholesterol may have attributed to such a
mechanism.
The higher level of plasma HDL-C indicates that more cho-
lesterol from peripheral tissues was returning to the liver for
catabolism and subsequent excretion. Plasma VLDL-C and
TG contents in mushroom-fed hypercholesterolemic rats were
lower compared with hypercholesterolemic rats. VLDL-C is
the major transport vehicle for TG from the liver to extrahe-
patic tissues, whereas LDL-C is not secreted as such in the liver
but seems to be formed from VLDL-C after partial removal of
TG by lipoprotein lipase (Mayes, 1997). LDL-C became the
prime carrier for cholesterol after feeding cholesterol to the
Table 2 Effects of Pleurotus eryngii on biochemical and electrolytes function in hypercholesterolemic rats.
Parameters NC HC HC+ PE
Albumin (g/dl) 3.3 ± 0.2 3.4 ± 0.3 3.0 ± 0.1
Total bilirubin (mg/dl) 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0
Direct bilirubin (mg/dl) 0.0 ± 0.0 0.0 ± 0.1 0.0 ± 0.0
Creatinine (mg/dl) 0.6 ± 0.0 0.7 ± 0.1 0.6 ± 0.1
Blood urea nitrogen (mg/dl) 16.2 ± 2.3a,b 17.4 ± 3.2a 14.2 ± 0.8b
Uric acid (mg/dl) 2.2 ± 0.5a 4.8 ± 1.4b 2.5 ± 1.6a
Glucose (mg/dl) 106.0 ± 4.7a,b 118.2 ± 10.7a 92.4 ± 6.9b
Total protein (g/dl) 7.2 ± 0.2 7.3 ± 0.4 6 ± 0.3
Calcium (mg/dl) 10.5 ± 0.2 10.9 ± 0.8 10.3 ± 0.2
Sodium (mEg/l) 142.8 ± 0.8 144.8 ± 2.3 143.4 ± 1.5
Potassium (mEg/l) 4.8 ± 0.3a 7.5 ± 1.7b 5.0 ± 0.5a,b
Chloride (mEg/l) 102.4 ± 1.5 103.0 ± 1.9 102.4 ± 0.9
Inorganic Phosphate (mg/dl) 6.9 ± 0.7a 11.6 ± 1.6b 7.3 ± 0.9a
Magnesium (mg/dl) 2.7 ± 0.2 3.6 ± 0.8 2.8 ± 0.3
Values are given means ± S.D. Values in the same row that do not share a common superscript are signiﬁcantly different at p 6 0.05.
Figure 2 Separation of plasma lipoproteins by agarose gel electrophoresis. Lanes 1–5 represent the plasma lipoprotein fraction of ﬁve
different rats from each group.
Figure 3 Effects of Pleurotus eryngii mushroom on the plasma
lipoprotein fraction following agarose gel electrophoresis. Values
represented are the means ± SD (n= 10). Different symbols
indicate signiﬁcant differences at p 6 0.05.
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HC+ PE rats.
3.5. Effect of Pleurotus eryngii on plasma biochemical and
electrolyte function
The results of the plasma biochemical and electrolytes concen-
trations indicated that, blood urea nitrogen, uric acid, glucose,
potassium, and inorganic phosphate in hypercholesterolemic
rats signiﬁcantly decrease by 18.39%, 47.92%, 21.83%,
33.33%, and 37.07%, respectively, compared with levels in
mushroom-fed hypercholesterolemic rats. In contrast no sig-
niﬁcant difference was found for plasma albumin, total biliru-
bin, direct bilirubin, creatinine, total protein, calcium, sodium,
and chloride levels among the normocholesterolemic, hyper-
cholesterolemic, and mushroom-fed hypercholesterolemic rats
(Table 2).
The glucose-lowering effect of propionate is associated with
gluconeogenesis and the regulation of serum lipid levels (Yang
et al., 2007). Reduction in plasma potassium, sodium, and
chloride concentrations is one of the mechanisms of action
of antihypertensive drugs, particularly diuretics (Jude et al.,
2010). Diuretics act by diminishing sodium chloride reabsorp-
tion at different sites in the nephrons, thereby increasing uri-
nary sodium chloride and water losses and consequently
leading to decreased plasma levels of these electrolytes. Anto-
nov et al. (1997) reported that plasma electrolyte contents in-
creased signiﬁcantly in hypertensive rats. Impaired function
of Na, K-ATPase and the Na-H antiport, which is typical ofarterial hypertension, may promote an increase in plasma
electrolytes.
3.6. Effect of Pleurotus eryngii on plasma lipoprotein fraction
The a-lipoprotein band was the fast-moving fraction and was
located nearest the anode. The b-lipoprotein band was usually
Figure 4 Effects of feeding Pleurotus eryngii mushroom on hepatocyte cells in hypercholesterolemic rats. A–C, hematoxylin–eosin
stained photomicrographs at 40·; D-C, photomicrographs of oil red O stain at 40·.
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ing only slightly anodic to the point of application. The pre-
b lipoprotein band migrated between a and b-lipoprotein
(Fig. 2). The effects of feeding P. eryngii on the plasma lipo-
protein fraction are presented in Fig. 3. The results indicated
no signiﬁcant difference in the lipoprotein fractions between
NC and HC+ PE rats. The results revealed that feeding 5%
mushrooms signiﬁcantly reduced plasma b-lipoprotein and
pre-b lipoprotein but increased a-lipoprotein.
The hypocholesterolemic effect of mushrooms is mediated
by the interplay of a complex mixture of substances (Bobek
et al., 1996). A water-soluble gel-forming component of the ﬁ-
ber substance interacts with bile acids and affects micelle for-
mation. Such substances might be interfering with the
absorption of cholesterol in this manner.
3.7. Effect of Pleurotus eryngii on rat liver histology
The effect of P. eryngii on hepatocyte cells of hypercholesterol-
emic rats has been presented in Fig. 4. Liver tissues were stained
with hematoxylin–eosin and oil red O. The hepatic cords were
typically arranged and located in liver tissue near the central
vein in the NC, HC, and HC + PE groups. Lipid droplets were
observed only in the liver tissue of HC rats. This could be
attributed to lipid accumulation in the hepatocyte cell
cytoplasm.
Oxidized LDL induces the expression of scavenger receptors
on the macrophage surface. These scavenger receptors promote
the accumulation of modiﬁed lipoproteins, forming an early
atheroma. The histological results indicated that the liver tis-
sues of HC+ PE rats were almost similar to NC rats and that
the hepatic biosynthesis of cholesterol was suppressed, which
might be due to a reduction in the activity of HMG-CoA (Keim
et al. 1982). Hyperlipidemia is the leading risk factor for athero-
sclerosis, but the atherosclerotic pathological process could be
slowed or reversed by reducing serum LDL, TGs, and PLs and
increasing serum HDL. Several studies have demonstrated a
protective effect of HDL in atherosclerosis and cardiovascular
disease, whereas high levels of LDL constitute a risk factor.
Excess LDL in the blood is deposited on the blood vessel wallsand becomes a major component of atherosclerotic plaque le-
sions, whereas HDL facilitates translocation of cholesterol
from peripheral tissues, such as arterial walls, to the liver for
catabolism (Li et al., 2010). Alam et al. (2011) observed that
oyster mushrooms prevented the formation of atheromatous
plaques and reduced the incidence and extent of atherosclerotic
lesions in the aorta and coronary arteries as well as focal ﬁbro-
sis in the myocardium of rabbits.
4. Conclusions
The present study demonstrated that feeding of 5% P. eryngii
fruiting bodies signiﬁcantly reduced the body weight and ath-
erogenic lipid proﬁles, and it had no detrimental effects on the
liver and kidney in hypercholesterolemic rats. On the basis of
the results, it is suggest that mushroom intake has signiﬁcant
health beneﬁts through the modulation of physiological func-
tions that consist of various atherogenic lipid proﬁles in hyper-
cholesterolemia. Therefore, P. eryngii can be a good source of
nutrition that may also act as a prophylactic against hypercho-
lesterolemia, hyperlipidemia and related complications, which
are the risk factors of atherosclerosis.Acknowledgments
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